Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits

Journal of Pharmaceutical Sciences

Volumn 99, Issue 1, 2010, Pages 119-127

  Afouna, Mohsen I ^a   Khedr, Alaa ^a   Abdel Naim, Ashraf B ^a   Al Marzoqi, Adnan ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Carbopol 934; Corneal transport; Glaucoma; IOP lowering effect; Mucoadhesive; Ocular delivery; Ocular enhancers; Terpene 4 ol

Indexed keywords

ADHESIVE AGENT; CARBOPOL 934; DORZOLAMIDE; TERPENE 4 OL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; EXPERIMENTAL RABBIT; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; MALE; MUCOADHESION; NONHUMAN;

EID: 73949094790     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21803     Document Type: Article

References (30)

1. Prausnitz MR, Noonan JS. 1998. Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye. J Pharm Sci 87:1479-1487.
2. Everitt DE, Avorn J. 1990. Systemic effects of medications used to treat glaucoma. Ann Intern Med 112:120-125. Review.
3. Jiahorng L, Robinson JR. 1992. The Effect of polyethylene glycol molecular weight on corneal transport and the related influence of penetration enhancers. Int J Pharm 88:125-140.
4. Janoria KG, Hariharan S, Dasari CR, Mitra AK. 2007. Recent patents and advances in ophthalmic drug delivery. Recent Pat Drug Deliv Formul 1:161-170.
5. Jarvinen K, Jarvinen T, Urtti A. 1995. Ocular absorption following topical delivery. Adv Drug Del Rev 1:3-19.
6. Blaug SM, Canada AT. 1965. Relationship of viscosity, contact time and prolongation of action of methylcellulose containing ophthalmic solutions. Am J Hosp Pharm 12:662-666.
7. Urtti A, Salminen L. 1993. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol 6:435-456.
8. Maren TH. 1995. The development of topical carbonic anhydrase inhibitors. J Glaucoma 4:49-62.
9. Sigurdsson H, Stefánssonb E, Gudmundsdóttir E, Eysteinssonc T, Thorsteinsdóttird M, Loftsson T. 2005. Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration. J Control Release 102:255-262.
10. Sugrue MF. 1996. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocular Pharmacol Ther 12:363-75.
11. Le HH, Chang MR, Cheng O, Lee DA, Hartenbaum D. 1999. The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications. J Ocul Pharmacol Ther 4:305-12.
12. Maren TH. 1984. The general physiology of reactions catalyzed by carbonic-anhydrase and their inhibition by sulfonamides. Ann NY Acad Sci 429: 568-579.
13. Maren TH. 1987. Carbonic-anhydrase general perspectives and advances in glaucoma research. Drug Dev Res 10:255-276.
14. Silver LH. 1998. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Am J Ophthalmol 126: 400-408.
15. Herkel U, Pfeiffer N. 2001. Update on topical carbonic anhydrase inhibitors. Curr Opin Ophthalmol 12:88-93.
16. Maruyama K, Shirato SJ. 2006. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: A prospective randomized crossover trial. Glaucoma 15:341-345.
17. Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R. 1998. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group. J Glaucoma 7:253-260.
18. Martínez A, Sánchez M. 2008. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: A single-center, 4-year, open-label study. Clin Ther 30:1120-1134.
19. Stephen Boyer OD, Dax Gay OD. 2008. Additive effect of dorzolamide hydrochloride to patients taking travoprost: A retrospective study. Optometry 79:501-504.
20. Quint M-P, Grove J, Thomas SM. 1999. Dorzolamide hydrochloride. Anal Profile Drug Substances Excipients 26:284-317.
21. Reddy IK, Vaithiyalingam SR, Khan MA, Bodor NS. 2001. Intraocular pressure-lowering activity and in vivo disposition of dipivalyl terbutalone in rabbits. Drug Dev Ind Pharm 27:137-141.
22. Afouna MI, Fincher TK, Zaghloul AA, Reddy IK. 2003. Effect of azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations against cutaneous HSV-1 infections and its correlation with skin target site free drug concentration using hairless mice. Int J Pharm 253:159-168.
23. Maltese A, Bucolo C. 2002. Rapid high-performance liquid chromatographic assay of dorzolamide in rabbit aqueous humor. Biomed Chromatogr 16: 274-276.
24. Erk N. 2002. Simultaneous determination of dorzolamide HCL and timolol maleate in eye drops by two different spectroscopic methods. J Pharm Biomed Anal 28:391-397.
25. Goskonda VR, Hill RA, Khan MA, Reddy IK. 2000. Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: A comparative study. PharmDev Technol 5:409-416.
26. Suhonen P, Järvinen T, Peura P, Urtti A. 1991. Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro. Int J Pharm 12: 169-176.
27. Suhonen P, Järvinen T, Rytkönen P, Peura P, Urtti A. 1991. Improved corneal pilocarpine permeability with O, O-(1,4-xylylene) bisilocarpic acid ester double ester prodrug, across albino rabbit cornea in vitro. Pharm Res 8:1539-1542.
28. Suhonen P, Järvinen T, Koivisto S, Urtti A. 1998. Different effects of pH on the permeation of pilocarpine prodrugs across the isolated rabbit cornea. Eur J Pharm Sci 6:169-176.
29. Afouna MI, Khattab SI, Reddy IK. 2005. Preparation and characterization of demeclocycline liposomal formulations and assessment of their intraocular pressure lowering effects using rabbit model. J Toxicol-Cutaneous Ocular Toxicol 24:111-124.
30. Melena J, Santafē J, Segarra J. 1998. The effect of topical diltiazem on the intraocular pressure in betamthasone-induced ocular hypertensive rabbits. J Pharmacol Exp Therap 264:282-287.